A Nigerian surgeon based in the United Kingdom has launched a new artificial intelligence platform aimed at addressing one of the most persistent challenges in modern healthcare: delays in clinical triage and specialist referrals.

Dr. Abduljabar Hamza, founder of London-based health technology startup, AiMedTech, has introduced MedBridge, an AI-driven clinical triage and referral optimisation system designed to integrate directly with hospital electronic medical record systems.

The platform is intended to help clinicians prioritise patient cases, route individuals to the appropriate specialists and reduce delays that frequently disrupt care pathways.

He said in an interview: “One of the biggest inefficiencies in healthcare is not necessarily diagnosis itself, but what happens before and after it, the triage process and how patients are referred through the system. 

“MedBridge is designed to help clinicians make those decisions faster, more consistently and with better data support.”

Healthcare systems across Europe and other developed regions are currently under pressure from workforce shortages, ageing populations and rising patient demand. 

According to Dr. Hamza, these pressures have exposed structural weaknesses in how patients are directed through healthcare systems.

“In many hospitals, triage and referral decisions still rely heavily on manual processes and fragmented information. That creates bottlenecks. Patients wait longer, clinicians are overwhelmed and resources are not always used efficiently.”

AiMedTech is positioning MedBridge not as a standalone clinical tool but as part of the underlying infrastructure that supports healthcare delivery.

“Our ambition is to build something similar to what Stripe did for online payments.  You don’t always see it, but it’s quietly running in the background, enabling systems to work more efficiently. We want MedBridge to become that infrastructure layer for clinical triage and referral management,” he said.